Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A C5a inhibitor in peritoneal fluid.

Y Matzner, A Brzezinski

The Journal of Laboratory and Clinical Medicine

|February 1, 1984

Summary

A novel protein inhibitor in peritoneal fluid blocks neutrophil chemotaxis triggered by zymosan-activated serum, but not f-met-leu-phe, suggesting a role in regulating serosal tissue inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

(Re)moving the needle: prospects for all-oral treatment for multidrug-resistant tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2017

Same author

Neutrophil Function in Hematological Neoplasia.

Leukemia & lymphoma·2016

Same author

Amino acid position 11 of HLA-DRβ1 is a major determinant of chromosome 6p association with ulcerative colitis.

Genes and immunity·2011

Same author

The relationship between maternal and fetal blood cholesterol.

Experimental medicine and surgery·2010

Same author

Determination of bilirubin in the umbilical blood as an aid in the early diagnosis of haemolytic disease in the newborn.

Nature·2010

Same author

Implantation of riboflavin pellets in animals and man.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·2010

Area of Science:

Immunology
Biochemistry
Cell Biology

Background:

Neutrophil recruitment is crucial for inflammatory responses.
Chemotaxis, the directed movement of neutrophils, is a key process in inflammation.
Aberrant neutrophil activity can contribute to inflammatory diseases.

Purpose of the Study:

To identify and characterize inhibitors of neutrophil chemotaxis in peritoneal fluid.
To investigate the mechanism of action and biochemical properties of the identified inhibitor.
To explore the potential role of this inhibitor in regulating inflammation in serosal tissues.

Main Methods:

Collection and analysis of peritoneal fluid.
Chemotaxis assays using neutrophils stimulated with zymosan-activated serum (including C5a) and f-met-leu-phe.
Incubation of neutrophils with peritoneal fluid to assess direct cellular effects.
Gel filtration chromatography to determine the molecular weight of the inhibitor.

Main Results:

Peritoneal fluid contains a protein inhibitor of neutrophil chemotaxis.
The inhibitor specifically targets chemotaxis induced by zymosan-activated serum/C5a, not f-met-leu-phe.
The inhibitor does not directly affect neutrophil function.
The inhibitor has an approximate molecular weight of 40,000 daltons.

Conclusions:

A novel protein inhibitor regulating neutrophil chemotaxis exists in peritoneal fluid.
This inhibitor selectively modulates inflammatory signaling pathways.
The findings suggest a role for this inhibitor in controlling inflammation within serosal cavities.

Related Experiment Videos